The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia

Neuropsychopharmacology

Volumn 21, Issue 6, 1999, Pages S134-S142

  Geyer, Mark A ^a,b   Krebs Thomson, Kirsten ^a,b   Varty, Geoffrey B ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT2A receptor; M100907; Prepulse inhibition; Rat; Schizophrenia; Serotonin; Startle

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; APOMORPHINE; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SOCIAL ISOLATION; STARTLE REFLEX;

EID: 0032803365     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00123-2     Document Type: Article

References (66)

1. Abi-Dargham A, Lamelle M, Aghajanian GK, Chamey D, Krystal J (1997): The role of serotonin in the pathophysi-ology and treatment of schizophrenia. J Neuropsychia-try ClinNeurosci 9:1-17
2. Bakshi VP, Geyer MA (1995): Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacol-ogy 122:198-201
3. Bakshi VP, Geyer MA (1997): Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, analpha-1noradrenergic antagonist. J PharmacolExpTher 283:666-674
4. Bakshi VP, Swerdlow NR, Braff DL, Geyer MA (1998): Reversal of isolation rearing-induced deficits in prepulseinhibition by Seroquel and olanzapine. Biol Psychiatry43:436-445
5. Bakshi VP, Swerdlow NR, Geyer MA (1994): Clozapine antagonizes phencyclidine-induced deficits in sen-sorimotor gating of the startle response. J PharmacolExpTher 271:787-794
6. Bolino F, di Michele V, di Cicco L, Manna V, Daneluzzo E, Cassachia M (1994): Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizo-phrenia. Biol Psychiatry 36:670-679
7. Braff DL, Grillon C, Geyer MA (1992): Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
8. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978): Prestimulus effects on human startle reflex in normalsand schizophrenics. Psychophysiology 15:339-343
9. Breier A (1995): Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14:187-202
10. Busatto GF, Kerwin RW (1997): Perspectives on the role of serotonergic mechanisms in the pharmacology ofschizophrenia. J Psychopharmacol 11:3-12
11. Cadenhead KS, Geyer MA, Braff DL (1993): Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150:1862-1867
12. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL (1997): Information processing deficits ofschizophrenia patients: Relationship to clinical ratings, gender and medication status. Schizophr Res 28:51-62
13. Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA (1990): Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses inrats. Psychopharmacology 102:1-4
14. Domino EF, Luby ED (1981): Abnormal mental states induced by phencyclidine as a model of schizophrenia.In Domino EF (ed), PCP (Phencyclidine): Historical andCurrent Perspectives. Ann Arbor, MI, NPP Books, pp400-418
15. Furuya Y, Kagaya T, Nishizawa Y, Ogura H (1998): Differential effects of the strychnine-insensitive glycine site antagonist + -HA-966 on the hyperactivity and the dis-ruption of prepulse inhibition induced by phencycli-dine in rats. Brain Res 781:227-235
16. Geyer MA, Swerdlow NR (1998): Measurement of startle response, prepulse inhibition, and habituation. InCrawley JN, Gerfen CR, McKay R, Rogawski MA, Sib-ley DR, Skolnick P (eds), Current Protocols in Neuro-science. New York, John Wiley & Sons, pp 8.7.1-8.7.15
17. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990): Startle response models of sensorimotor gating andhabituation deficits in schizophrenia. Brain Res Bull25:485-498
18. Geyer MA, Wilkinson LS, Humby T, Robbins TW (1993): Isolation rearing of rats produces a deficit in prepulseinhibition of acoustic startle similar to that in schizo-phrenia. Biol Psychiatry 34:361-372
19. Goyer PF, Berridge MS, Morris ED, Semple WE, Compton-Toth BA, Schulz SC, Wong DF, Miraldi F, Meltzer HY (1996): PET measurement of neuroreceptor occupancyby typical and atypical neuroleptics. J Nucl Med37:1122-1127
20. Grillon C, Ameli R, Charney DS, Krystal J, Braff D (1992): Startle gating deficits occur across prepulse intensitiesin schizophrenic patients. Biol Psychiatry 32:939-943
21. Grillon C, Courchesne E, Ameli R, Geyer MA, Braff DL (1990): Increased distractibility in schizophrenic patients: Electrophysiological and behavioral evidence. Arch Gen Psychiatry 47:171-179
22. Gurevich EV, Joyce JN (1997): Alterations in the cortical serotonergic system in schizophrenia: A postmortemstudy. Biol Psychiatry 42:529-545
23. Harrison PJ, Burnet PW (1997): The 5-HT2A (serotonin2A) receptor gene in the aetiology, pathophysiology andpharmacotherapy of schizophrenia. J Psychopharmacol11:18-20
24. Hoffman DC, Donovan H, Cassella JV (1993): The effects of haloperidol and clozapine on the disruption of sen-sorimotor gating induced by the noncompetitiveglutamate antagonist MK-801. Psychopharmacology111:339-344
25. Hoffman HS, Ison JR (1980): Reflex modification in the domain of startle: I. Some empirical findings and theirimplication for how the nervous system processes sen-sory input. Psychol Rev 87:175-189
26. Hollister LE (1969): Steroids and moods: Correlations in schizophrenics and subjects treated with lysergic aciddiethylamide (LSD), mescaline, tetrahydrocannabinol, and synhexyl. J ClinPharmacol J New Drugs 9:24-29
27. Issa F, Gerhardt GA, Bartko JJ, Suddath RL, Lynch M, Gama-che PH, Freedman R, Wyatt RJ, Kirch DG (1994): A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia. I. Comparisonswith healthy control subjects and neuroleptic-treated/unmedicatedpairs analyses. Psychiatry Res 52:237-249
28. Javitt DC, Zukin SR (1991): Recent advances in the phency-clidine model of schizophrenia. Am J Psychiatry 10:1301-1308
29. Johansson C, Jackson DM, Svensson L (1994): The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.Psychopharmacology 116:437-442
30. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993): Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizo-phrenics. Neuropsychopharmacology 8:315-336
31. Karper LP, Grillon C, Charney DS, Krystal JH (1994): The effect of ketamine on pre-pulse inhibition and attention.Proc Am Coll Neuropsychopharmacol:124
32. Keith VA, Mansbach RS, Geyer MA (1991): Failure of haloperidol to block the effects of phencyclidine and dizo-cilpine on acoustic startle prepulse inhibition. Biol Psychiatry 30:557-566
33. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995a): Ketamine activates psychosis and alters limbic bloodflow in schizophrenia. NeuroReport 6:869-872
34. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995b): Sub-anesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19
35. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelly R (1959): Study of a new schizophrenomimetic drug-Ser-nyl. AmA Arch Neurol Psychiatry 81:363-369
36. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997): Ketamine-induced exacerbation of psychotic symptoms and cognitive impairmentin neuroleptic-free schizophrenics. Neuropsychophar-macology 17:41-50
37. Mansbach RS, Brooks EW, Sanner MA, Zorn SH (1998): Selective dopamine D4 receptor antagonists reverseapomorphine-induced blockade of prepulse inhibition.Psychopharmacology 135:194-200
38. Mansbach RS, Geyer MA (1989): Effects of phencyclidine and phencyclidine biologs on sensorimotor gating inthe rat. Neuropsychopharmacology 2:299-308
39. Mansbach RS, Geyer MA (1991): Parametric determinants in pre-stimulus modification of acoustic startle: Interaction with ketamine. Psychopharmacology 105:162-168
40. Mansbach RS, Geyer MA, Braff DL (1988): Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psy-chopharmacology 94:507-514
41. McGhie A, Chapman J (1961): Disorders of attention and perception in early schizophrenia. Br J Med Psychol34:102-116
42. Meltzer HY (1995b): Role of serotonin in the action of atypical antipsychotic drugs. ClinNeurosci 3:64-75
43. Meltzer HY (1995a): The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist anti-psychotics. J ClinPsychopharmacol 15:2S-3S
44. Moghaddam B (1994): Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. ProgNeuropsychopharmacolBiol Psychiatry 18:859-870
45. Nyberg S, Farde L (1997): The relevance of serotonergic mechanisms in the treatment of schizophrenia has notbeen confirmed. J Psychopharmacol 11:13-14
46. Padich RA, McCloskey TC, Kehne JH (1996): 5-HT modulation of auditory and visual sensorimotor gating. II. Effects of the 5-HT2Aantagonist MDL 100, 907 on disrup-tion of sound and light prepulse inhibition produced by5-HT agonists in Wistar rats. Psychopharmacology124:107-116
47. Rasmussen K, Gates MR, Burger JE, Czachura JF (1997): The novel atypical antipsychotic olanzapine, but not theCCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition. NeurosciLett 222:61-64
48. Rigdon GC (1990): Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two ratstrains. Psychopharmacology 102:419-421
49. Rigdon GC, Viik K (1991): Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res 23:91-99
50. Sipes TA, Geyer MA (1994): Multiple serotonin receptor sub-types modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448
51. Sipes TE, Geyer MA (1995): DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2Aand not by 5-HT2Creceptors. BehavPharmacol 6:839-842
52. Sipes TE, Geyer MA (1997): DOI disrupts prepulse inhibition of startle in rats via 5-HT2Areceptors in the ventral pallidum. Brain Res 761:97-104
53. Swerdlow NR, Bakshi VP, Geyer MA (1996): Seroquel restores sensorimotor gating in phencyclidine-treatedrats. J PharmacolExpTher 279:1290-1299
54. Swerdlow NR, Bakshi VP, Waikar M, Taaid N, Geyer MA (1998b): Seroquel, clozapine and chlorpromazine, butnot haloperidol, restore sensorimotor gating in ket-amine treated rats. Psychopharmacology 140:75-80
55. Swerdlow NR, Caine SB, Geyer MA (1992): Regionally sel-ective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 108:189-195
56. Swerdlow NR, Geyer MA (1993): Clozapine and haloperidol in an animal model of sensorimotor gating deficits inschizophrenia. PharmacolBiochemBehav 44:741-744
57. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991): Effects of spiperone, raclopride, SCH 23390 and clozapine onapomorphine inhibition of sensorimotor gating of thestartle response in the rat. J PharmacolExpTher256:530-536
58. Swerdlow NR, Varty GB, Geyer MA (1998a): Discrepant findings of clozapine effects on prepulse inhibition ofstartle: Is it the route or the rat? Neuropsychopharmacology 18:50-56
59. Swerdlow NR, Zisook D, Taaid N (1994): Seroquel ICI 204, 636 restores prepulse inhibition of acoustic startle inapomorphine-treated rats: Similarities to clozapine.Psychopharmacology 114:675-678
60. Varty GB, Bakshi VP, Geyer MA (1999): M100907, a serotonin 5-HT2Areceptor antagonist and putative antipsy-chotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsy-chopharmacology 20:311-321
61. Varty GB, Higgins GA (1994): Differences between three rat strains in sensitivity to prepulse inhibition of an acous-tic startle response: influence of apomorphine andphencyclidine pretreatment. J Psychopharmacol 8:148-156
62. Varty GB, Higgins GA (1995b): Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psy-chopharmacology 122:15-26
63. Varty GB, Higgins GA (1995a): Reversal of dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ket-anserin. Eur J Pharmacol 287:201-205
64. Venables PH (1960): The effect of auditory and visual stimulation on the skin potential responses of schizophrenics. Brain 83:77-92
65. Weike A, Globisch J, Hamm A, Bauer U (1996): Prepulse inhibition and habituation of skin conductanceresponses in schizophrenics: Neuroleptic drug effects.Psychophysiology 33:S88
66. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994): Social isolation in the rat producesdevelopmentally specific deficits in prepulse inhibitionof the acoustic startle response without disruptinglatent inhibition. Neuropsychopharmacology 10:61-72